Page last updated: 2024-08-22

cladribine and Brain Diseases

cladribine has been researched along with Brain Diseases in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	5 (83.33)	29.6817
2010's	1 (16.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Inoue, M; Kawa, K; Nakayama, M; Sawada, A; Yamada, K; Yasui, M	1
Li, CY; Pardanani, A; Phyliky, RL; Tefferi, A	1
Finlay, JL; Kupersmith, MJ; Tikoo, RK	1
Adam, Z; Belohlavek, O; Büchler, T; Cervinek, L; Kantorova, I; Mechl, M; Nebesky, T; Vorlicek, J	1
McClain, KL	1
Lange, BJ; Nichols, KE; Orsey, A; Paessler, M	1

Reviews

1 review(s) available for cladribine and Brain Diseases

Article	Year
Drug therapy for the treatment of Langerhans cell histiocytosis. Expert opinion on pharmacotherapy, 2005, Volume: 6, Issue:14 Topics: Anti-Inflammatory Agents; Antimetabolites; Brain Diseases; Cell Proliferation; Cladribine; Cytarabine; Drug Therapy, Combination; Histiocytosis, Langerhans-Cell; Humans; Immunosuppressive Agents; Mercaptopurine; Practice Guidelines as Topic; Prednisone; Randomized Controlled Trials as Topic; Risk Factors; Secondary Prevention; Thalidomide; Vinblastine	2005

Article

Year

Drug therapy for the treatment of Langerhans cell histiocytosis.

Expert opinion on pharmacotherapy, 2005, Volume: 6, Issue:14

Topics: Anti-Inflammatory Agents; Antimetabolites; Brain Diseases; Cell Proliferation; Cladribine; Cytarabine; Drug Therapy, Combination; Histiocytosis, Langerhans-Cell; Humans; Immunosuppressive Agents; Mercaptopurine; Practice Guidelines as Topic; Prednisone; Randomized Controlled Trials as Topic; Risk Factors; Secondary Prevention; Thalidomide; Vinblastine

2005

Other Studies

5 other study(ies) available for cladribine and Brain Diseases

Article	Year
Severe persistent bone marrow failure following therapy with 2-chlorodeoxyadenosine for relapsing juvenile xanthogranuloma of the brain. Pediatric blood & cancer, 2012, Volume: 58, Issue:2 Topics: Anemia, Aplastic; Bone Marrow Diseases; Bone Marrow Failure Disorders; Bone Marrow Transplantation; Brain Diseases; Child; Cladribine; Hemoglobinuria, Paroxysmal; Humans; Immunosuppressive Agents; Male; Prognosis; Recurrence; Transfusion Reaction; Xanthogranuloma, Juvenile	2012
2-Chlorodeoxyadenosine therapy for disseminated Langerhans cell histiocytosis. Mayo Clinic proceedings, 2003, Volume: 78, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Bone Marrow; Brain Diseases; Cladribine; Female; Herpes Zoster; Histiocytosis, Langerhans-Cell; Humans; Immunosuppressive Agents; Male; Middle Aged; Retrospective Studies	2003
Treatment of refractory neurosarcoidosis with cladribine. The New England journal of medicine, 2004, 04-22, Volume: 350, Issue:17 Topics: Blindness; Brain Diseases; Cladribine; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Middle Aged; Prednisone; Sarcoidosis	2004
Langerhans cell histiocytosis with central nervous system involvement: follow-up by FDG-PET during treatment with cladribine. Pediatric blood & cancer, 2005, Volume: 44, Issue:3 Topics: Adolescent; Adult; Antineoplastic Agents; Brain Diseases; Child; Child, Preschool; Cladribine; Fluorodeoxyglucose F18; Follow-Up Studies; Histiocytosis, Langerhans-Cell; Humans; Male; Positron-Emission Tomography	2005
Central nervous system juvenile xanthogranuloma with malignant transformation. Pediatric blood & cancer, 2008, Volume: 50, Issue:4 Topics: Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Brain Neoplasms; Child; Cladribine; Dexamethasone; Diagnosis, Differential; Disease Progression; Fatal Outcome; Histiocytic Sarcoma; Humans; Immunohistochemistry; In Situ Hybridization, Fluorescence; Magnetic Resonance Imaging; Male; Pseudotumor Cerebri; Radiotherapy; Xanthogranuloma, Juvenile	2008